Methylation of the 5' CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas

Cancer Research

Volumn 58, Issue 15, 1998, Pages 3429-3434

  Tanaka, Hisashi ^a,b,c   Shimada, Yutaka ^b   Harada, Hideki ^a,b   Shinoda, Masayuki ^a   Hatooka, Syunzo ^a   Imamura, Masayuki ^b   Ishizaki, Kanji ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; ESOPHAGUS CARCINOMA; GENE REPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ACID ANHYDRIDE HYDROLASES; ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; EXONS; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEINS; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED;

EID: 0032145266     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Shibagaki, I., Shimada, Y., Wagata, T., Ikenaga, M., Imamura, M., and Ishizaki, K. Allelotype analysis of esophageal squamous cell carcinoma. Cancer Res., 54: 2996-3000, 1994.
2. Mori, T., Yanagisawa, A., Kato, Y., Miura, K., Nishihira, T., Mori, S., and Nakamura, Y. Accumulation of genetic alterations during esophageal carcinogenesis. Hum. Mol. Genet., 3: 1969-1971, 1994.
3. Ogasawara, S., Maesawa, C., Tamura, G., and Satodate, R. Frequent microsatellite alterations on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res., 55: 891-894, 1995.
4. Ohta, M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa, R., Palazzo, J., Siprashvili, Z., Mori, M., McCue, P., Druck, T., Croce, M., and Huebner, K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell, 84: 587-597, 1996.
5. Barnes, L. D., Garrison, P. N., Siprashvili, Z., Guranowski, A., Robinson, A. K., Ingram, S. W., Croce, C. M., Ohta, M., and Huebner, K. Fhit, a putative tumor suppressor in humans, is a dinucleotide 5′,5‴-P1, P3-triphosphate hydrolase. Biochemistry, 35: 11529-11535, 1996.
6. Siprashvili, Z., Sozzi, G., Barnes, L. D., McCue, P., Robinson, A. K., Eryomin, V., Sard, L., Tagliabue, E., Greco, A., Fusetti, L., Schwartz, G., Pierotti, M. A., Croce, C. M., and Huebner, K. Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc. Natl. Acad. Sci. USA, 94: 13771-13776, 1997.
7. Sozzi, G., Veronese, M. L., Negrini, M., Baffa, R., Cotticelli, M. G., Inoue, H., Tornielli, S., Pilotti, S., De Gregorio, L., Pastorino, U., Pierotti, M. A., Ohta, M., Huebner, K., and Croce, C. M. The FHIT gene 3p14.2 is abnormal in lung cancer. Cell, 85: 17-26, 1996.
8. Sozzi, G., Alder, H., Tornielli, S., Corletto, V., Baffa, R., Veronese, M. L., Negrini, M., Pilotti, S., Pierotti, M. A., Huebner, K., and Croce, C. M. Aberrant FHIT transcripts in Merkel cell carcinoma. Cancer Res., 56: 2472-2474, 1996.
9. Negrini, M., Monaco, C., Vorechovsky, I., Ohta, M., Druck, T., Baffa, R., Huebner, K., and Croce, C. M. The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Cancer Res., 56: 3173-3179, 1996.
10. Virgilio, L., Shuster, M., Gollin, S. M., Veronese, M. L., Ohta, M., Huebner, K., and Croce, C. M. FHIT gene alterations in head and neck squamous cell carcinomas. Proc. Natl. Acad. Sci. USA, 93: 9770-9775, 1996.
11. Mao, L., Fan, Y. H., Lotan, R., and Hong, W. K. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. Cancer Res., 56: 5128-5131, 1996.
12. Yanagisawa, K., Kondo, M., Osada, H., Uchida, K., Takagi, K., Masuda, A., Takahashi, T., and Takahashi, T. Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines. Cancer Res., 56: 5579-5582, 1996.
13. Inoue, H., Ishii, H., Alder, H., Snyder, E., Druck, T., Huebner, K., and Croce, C. M. Sequence of the FRA3B common fragile region: implications for the mechanism of FHIT deletion. Proc. Natl. Acad. Sci. USA, 94: 14584-14589, 1997.
14. Gemma, A., Hagiwara, K., Ke, Y., Burke, L. M., Khan, M. A., Nagashima, M., Bennett, W. P., and Harris, C. C. FHIT mutations in human primary gastric cancer. Cancer Res., 57: 1435-1437, 1997.
15. Ahmadian, M., Wistuba, I.I., Fong, K. M., Behrens, C., Kodagoda, D. R., Saboorian, M. H., Shay, J., Tomlinson, G. E., Blum, J., Minna J. D., and Gazdar, A. F. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands. Cancer Res., 57: 3664-3668, 1997.
16. Sozzi, G., Tornielli, S., Tagliabue, E., Sard, L., Pezzella, F., Pastorino, U., Minoletti, F., Pilotti, S., Ratcliffe, C., Veronese, M. L., Goldstraw, P., Huebner, K., Croce, C. M., and Pierotti, M. A. Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities. Cancer Res., 57: 5207-5212, 1997.
17. Greenspan, D. L., Connolly, D. C., Wu, R., Lei, R. Y., Vogelstein, J. T., Kim, Y. T., Mok, J. E., Munoz, N., Bosch, F. X., Shah, K., and Cho, K. R. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Cancer Res., 57: 4692-4698, 1997.
18. Zou, T. T., Lei, J., Shi, Y. Q., Yin, J., Wang, S., Souza, R. F., Kong, D., Shimada, Y., Smolinski, K. N., Greenwald, B. D., Abraham, J. M., Harpaz, N., and Meltzer, S. J. FHIT gene alterations in esophageal cancer and ulcerative colitis (UC). Oncogene, 15: 101-105, 1997.
19. Sakai, T., Toguchida, J., Ohtani, N., Yandell, D. W., Rapaport, J. M., and Dryja, T. P. Allele-specific hypermethylation of the netinoblastoma tumor-suppressor gene. Am. J. Hum. Genet., 48: 880-888, 1991.
20. Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S., Gnarra, J. R., Linehan, W. M., and Baylin, S. B. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA, 91: 9700-9704, 1994.
21. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1: 686-692, 1995.
22. Herman, J. G., Merlo, A., Mao, L., Lapidus, R. G., Issa, J. P., Davidson, N. E., Sidransky, D., and Baylin, S. B. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55: 4525-4530, 1995.
23. Jones P. A. DNA methylation errors and cancer. Cancer Res., 56: 2643-2647, 1996.
24. Bender, C. M., Pao, M., and Jones, P. A. Inhibition of DNA methylation by 5-aza-2′-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res., 58: 95-101, 1997.
25. Maesawa, C., Tamura, G., Nishizuka, S., Ogasawara, S., Ishida, K., Terashima, M., Sakata, K., Sato, N., Saito, K., and Satodate, R. Inactivation of the CDKN2 gene by homozygous deletion and de novo methylation is associated with advanced stage esophageal squamous cell carcinoma. Cancer Res., 56: 3875-3878, 1996.
26. Tanaka, H., Shimada, Y., Imamura, M., Shibagaki, I., and Ishizaki, K. Multiple types of aberrations in the p16 (INK4a) and the p15(INK4b) genes in 30 esophageal squamous-cell-carcinoma cell lines. Int. J. Cancer, 70: 437-442, 1997.
27. Shimada, Y., Imamura, M., Wagata, T., Yamaguchi, N., and Tobe, T. Characterization of 21 newly established esophageal cancer cell lines. Cancer (Phila.), 69: 277-284, 1992.
28. Druck, T., Hadaczek, P., Fu, T. B., Ohta, M., Siprashvili, Z., Baffa, R., Negrini, M., Kastury, K., Veronese, M. L., Rosen, D., Rothstein, J., McCue, P., Cotticelli, M. G., Inoue, H., Croce, C. M., and Huebner, K. Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res., 57: 504-512, 1997.
29. Kukita, Y., Tahira, T., Sommer, S. S., and Hayashi, K. SSCP analysis of long DNA fragments in low pH gel. Hum. Mutat., 10: 400-407, 1997.
30. Clark, S. J., Harrison, J., Paul, C. L., and Frommer, M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res., 22: 2990-2997, 1994.
31. Graff, J. R., Herman, J. G., Myohanen, S., Baylin, S. B., and Vertino, P. M. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J. Biol. Chem., 272: 22322-22329, 1997.
32. Gardiner-Garden, M., and Frommer, M. CpG islands in vertebrate genomes. J. Mol. Biol., 196: 261-282, 1987.
33. Brandeis, M., Frank, D., Keshet, I., Siegfried, Z., Mendelsohn, M., Nemes, A., Temper, V., Razin, A., and Cedar, H. Sp1 elements protect a CpG island from de novo methylation. Nature (Lond.), 371: 435-438, 1994.
34. Lewis, J. D., Meehan, R. R., Henzel, W. J., Maurer-Fogy, I., Jeppesen, P., Klein, F., and Bird, A. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell, 69: 905-914, 1992.
35. Nan, X., Campoy, F. J., and Bird, A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell, 88: 471-481, 1997.
36. Sakai, T., Ohtani, N., McGee, T. L., Robbins, P. D., and Dryja, T. P. Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene. Nature (Lond.), 353: 83-86, 1991.